Anxiolytic activity of root extracts of Cardiospermum halicacabum in mice

Internet Journal of Pharmacology

Volumn 7, Issue 1, 2009, Pages

  Malaviya, Shailesh ^a   Nandakumar, K ^a   Vaghasiya, J D ^b   Bhalodiya, Y S ^b   Jivani, N P ^b   Sheth, N ^c   Manek, R A ^d   Chauhan, S P ^d  

^a PES COLLEGE OF PHARMACY   (India)

^b RBPMPC ^*  (India)

^c SAURASHTRA UNIVERSITY   (India)

^d RBPMPC   (India)

Author keywords

Anxiety; Cardiospermum halicacabum; Elevated plus maze (EPM); Light dark model; Open field test

Indexed keywords

ANXIOLYTIC AGENT; CARDIOSPERMUM HALICACABUM EXTRACT; DIAZEPAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PLANT ROOT; TRANQUILIZING ACTIVITY;

EID: 77953414529     PISSN: None     EISSN: 15312976     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Joshi SK, Dhstms BD, Bhatia CR, Singh RV, Thakur RS. 1992. The wealth of India Raw Materials vol. III, New Delhi; Council of Scientific Ind Res pub 270-71. (s)
2. Gopalkrishnan C, Dhananjayan R, Kameswaran L. 1976. Studies on the pharmacological actions of Cardiospermum halicacabum. Ind J Physiol Pharmacol 20: 203-6. (s)
3. Chopra RN, Glossary of Indian Medicinal Plants, New Delhi; 1980. Council for Scientific Ind Res 51-55. (s)
4. Nadkarni KM, 1976. Ind Materia Medica, Popular Book Depot, Bombay 271. (s)
5. Sheeba MS, Asha VV. 2006. Effect of Cardiospermum halicacabum on ethanol induced gastric ulcer in rats. J Ethnopharmacol 106:105-10. (s)
6. Boonmars T, Khunkitti W, Sithithaworn P, Fujimaki Y. 2005. In vitro antiparasitic activity of extract of Cardiospermum halicacabum against third-stage larvae of strongyloides stercoralis. Parasitol Res 97 (5):417-19. (s)
7. Wakko PJ, Gumede B, Smith P, Folb PI. 2005. The in vitro and in vivo antimalarial activity of Cardiospermum halicacabum L. J Ethanopharmacol 99: 137-43. (s)
8. Khunkitti W, Fujimaki Y, Aoki Y. 2000. In vitro antifilarial activity of extract of themedicinal plant Cardiospermum halicacabum against brugia pahangi. J Helminthol 74 (3):241-46. (s)
9. Asha VV, Pushpangadan P. 1999. Antipyretic activity of Cardiospermum halicacabum. Ind J Expt Biol 37: 411-14. (s)
10. Venkteshbabu KC, Krishnakumari S. 2006. Cardiospermum halicacabum suppress the production of TNF-alpha Nitric oxide by Human peripheral blood mononuclear cells. Afr J biomed Res 9: 95-99. (s)
11. Santhakumari G. 1981. Diuretic acitivity of Cardiospermum halicacabum Linn. in rats. J Scientific Res. Plant Med 2: 32. (s)
12. K.R.Khandelwal; 1999. 'Practical Pharmacology & Experiments', 6th Ed., Nirali Prakashan; Pune (s)
13. Kokate CK, Purohit AP, Gokhale SB. 1996. Text book of pharmacognosy, Nirali Prakashan, Pune 4: 510-11. (s)
14. Hogg SA. 1996. Review of the validity and Variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54: 21-30. (s)
15. Pellow S, File SE. 1986. Anxiolytic and axiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24: 525-29. (s)
16. P.M.Brostine, A.K.Jaiswal, S.K.Bhattacharya, S.B.Acharya; 1994. Ind J Exp Biol 32: 489-91. (s)
17. Rabbani M, Sajjadi SE, Zarei HR. 2003. Anxiolytic effects of Stachys lavandulifolia on the elevated plus-maze model of anxiety in mice. J Ethnopharmacol 89: 271-76. (s)
18. Mortgomery KC. 1955. The relation between fear induced by novel and exploratory behaviour. J Comp Physiol Psychol 48: 254-60. (s)
19. French JA. 1995. Pseudo seizures in the era of videoelectroencephalogram monitoring. Cur Opin Neurol 8: 117-20. (s)
20. Duncan JS. 1997. Imaging and epilepsy, Brain 120: 339-77. (s)
21. Brodie MJ, Dichter MA. 1996. Antiepileptic drugs. N Engl J Med 334: 168-75. (s)
22. Mattson RH, Cramer JA, Collins IF. et al., 1985. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondary tonic-clonic seizures, N Engl J Med 313:145-51. (s)
23. Dalziel D, Uthman B, Mcgorray S, Reep R. 2003. Seizure-alert dogs: a review and preliminary study. Seizure 12 (2):115-20. (s)